• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过表达 Nurr1 的神经干细胞和小胶质细胞移植治疗帕金森病大鼠。

Transplantation of Nurr1-overexpressing neural stem cells and microglia for treating parkinsonian rats.

机构信息

Yunnan Key Laboratory of Laboratory Medicine, Yunnan Engineering Technology Center of Digestive disease, 1st Affiliated Hospital of Kunming Medical University, Kunming, China.

Genetic Diagnosis Center, Women and Children Hospital, Kunming, China.

出版信息

CNS Neurosci Ther. 2020 Jan;26(1):55-65. doi: 10.1111/cns.13149. Epub 2019 May 13.

DOI:10.1111/cns.13149
PMID:31087449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930818/
Abstract

BACKGROUND

Neural stem cells (NSCs) transplantation is considered a promising treatment for Parkinson's disease. But most NSCs are differentiated into glial cells rather than neurons, and only a few of them survive after transplantation due to the inflammatory environment.

METHODS

In this study, neural stem cells (NSCs) and microglial cells both forced with the Nurr1 gene were transplanted into the striatum of the rat model of PD. The results were evaluated through reverse transcription polymerase chain reaction (RT-PCR), Western blot, and immunofluorescence analysis.

RESULTS

The behavioral abnormalities of PD rats were improved by combined transplantation of NSCs and microglia, both forced with Nurr1. The number of tyrosine hydroxylase+ cells in the striatum of PD rats increased, and the number of Iba1+ cells decreased compared with the other groups. Moreover, the dopamine neurons differentiated from grafted NSCs could still be detected in the striatum of PD rats after 5 months.

CONCLUSIONS

The results suggested that transplantation of Nurr1-overexpressing NSCs and microglia could improve the inhospitable host brain environments, which will be  a new potential strategy for the cell replacement therapy in PD.

摘要

背景

神经干细胞(NSCs)移植被认为是治疗帕金森病的一种有前途的方法。但是,大多数 NSCs 分化为神经胶质细胞而不是神经元,并且由于炎症环境,只有少数 NSCs 在移植后存活。

方法

在这项研究中,将强制表达 Nurr1 基因的神经干细胞(NSCs)和小胶质细胞都移植到 PD 大鼠模型的纹状体中。通过逆转录聚合酶链反应(RT-PCR)、Western blot 和免疫荧光分析评估结果。

结果

联合移植强制表达 Nurr1 的 NSCs 和小胶质细胞可改善 PD 大鼠的行为异常。与其他组相比,PD 大鼠纹状体中酪氨酸羟化酶+细胞的数量增加,Iba1+细胞的数量减少。此外,在 PD 大鼠的纹状体中仍可检测到源自移植 NSCs 的多巴胺神经元。

结论

这些结果表明,移植过表达 Nurr1 的 NSCs 和小胶质细胞可以改善宿主大脑的不利环境,这将成为 PD 细胞替代治疗的新潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/11462746eef3/CNS-26-55-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/d7ec0932db74/CNS-26-55-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/babe4a926950/CNS-26-55-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/67234a26ece6/CNS-26-55-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/d3d28679376b/CNS-26-55-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/356fa1de4d26/CNS-26-55-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/4743406694be/CNS-26-55-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/c0718cdf39af/CNS-26-55-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/23ecc7150036/CNS-26-55-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/9b9c166df323/CNS-26-55-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/11462746eef3/CNS-26-55-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/d7ec0932db74/CNS-26-55-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/babe4a926950/CNS-26-55-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/67234a26ece6/CNS-26-55-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/d3d28679376b/CNS-26-55-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/356fa1de4d26/CNS-26-55-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/4743406694be/CNS-26-55-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/c0718cdf39af/CNS-26-55-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/23ecc7150036/CNS-26-55-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/9b9c166df323/CNS-26-55-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184a/6930818/11462746eef3/CNS-26-55-g010.jpg

相似文献

1
Transplantation of Nurr1-overexpressing neural stem cells and microglia for treating parkinsonian rats.过表达 Nurr1 的神经干细胞和小胶质细胞移植治疗帕金森病大鼠。
CNS Neurosci Ther. 2020 Jan;26(1):55-65. doi: 10.1111/cns.13149. Epub 2019 May 13.
2
Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats.用Nurr1和Brn4共转染的神经干细胞移植治疗帕金森病大鼠。
Int J Dev Neurosci. 2013 Feb;31(1):82-7. doi: 10.1016/j.ijdevneu.2012.10.007. Epub 2012 Oct 17.
3
Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia.Nurr1 促进神经干细胞和小胶质细胞转孔共培养体系中多巴胺能神经元的神经发生,并抑制炎症因子。
CNS Neurosci Ther. 2018 Sep;24(9):790-800. doi: 10.1111/cns.12825. Epub 2018 Feb 15.
4
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.二十二碳六烯酸促进诱导多能干细胞中多巴胺能分化,并抑制帕金森样病理大鼠中的畸胎瘤形成。
Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7.
5
Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.成纤维细胞生长因子-20促进过表达Nurr1的神经干细胞分化为酪氨酸羟化酶阳性神经元。
Neurobiol Dis. 2004 Nov;17(2):163-70. doi: 10.1016/j.nbd.2004.07.007.
6
Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.环境线索依赖性多巴胺能神经元分化和移植神经上皮干细胞在帕金森病脑中的功能影响。
Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76.
7
The co-transduction of Nurr1 and Brn4 genes induces the differentiation of neural stem cells into dopaminergic neurons.Nurr1 和 Brn4 基因的共转导诱导神经干细胞向多巴胺能神经元分化。
Cell Biol Int. 2011 Dec;35(12):1217-23. doi: 10.1042/CBI20110028.
8
Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.神经干细胞移植联合硬脂酸乙酯通过促进神经干细胞迁移和分化改善 PD 大鼠的运动行为。
CNS Neurosci Ther. 2023 Jun;29(6):1571-1584. doi: 10.1111/cns.14119. Epub 2023 Mar 16.
9
Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene.用携带NURR1基因的重组腺病毒载体转染过表达NURR1的C17.2神经干细胞治疗帕金森病。
Synapse. 2007 Dec;61(12):971-7. doi: 10.1002/syn.20449.
10
A high-efficiency induction of dopaminergic cells from human umbilical mesenchymal stem cells for the treatment of hemiparkinsonian rats.从人脐间充质干细胞高效诱导多巴胺能细胞用于治疗偏侧帕金森病大鼠
Cell Transplant. 2015;24(11):2251-62. doi: 10.3727/096368914X685078. Epub 2014 Oct 6.

引用本文的文献

1
The subventricular zone structure, function and implications for neurological disease.脑室下区的结构、功能及其对神经系统疾病的影响。
Genes Dis. 2024 Aug 26;12(3):101398. doi: 10.1016/j.gendis.2024.101398. eCollection 2025 May.
2
Therapeutic role of neural stem cells in neurological diseases.神经干细胞在神经系统疾病中的治疗作用。
Front Bioeng Biotechnol. 2024 Mar 7;12:1329712. doi: 10.3389/fbioe.2024.1329712. eCollection 2024.
3
Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson's disease.

本文引用的文献

1
Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model.移植星形胶质细胞可改善帕金森病模型中的细胞治疗效果。
J Clin Invest. 2018 Jan 2;128(1):463-482. doi: 10.1172/JCI93924. Epub 2017 Dec 11.
2
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.帕金森病的过去、现在和未来:震颤麻痹 200 周年专论。
Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115.
3
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.Nurr1:RXRα 异二聚体激活作为帕金森病的单一疗法。
人类神经干细胞移植可预防帕金森病大鼠模型出现有症状的运动行为障碍。
Open Life Sci. 2024 Feb 24;19(1):20220834. doi: 10.1515/biol-2022-0834. eCollection 2024.
4
Transplanting Microglia for Treating CNS Injuries and Neurological Diseases and Disorders, and Prospects for Generating Exogenic Microglia.用于治疗中枢神经系统损伤和神经疾病及障碍的小胶质细胞移植和外源性小胶质细胞的生成的前景
Cell Transplant. 2023 Jan-Dec;32:9636897231171001. doi: 10.1177/09636897231171001.
5
Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF-KB pathway.青蒿素通过 TLR4/Myd88/NF-KB 通路抑制小胶质细胞激活,在 MPTP 帕金森病小鼠模型中发挥保护作用。
CNS Neurosci Ther. 2023 Apr;29(4):1012-1023. doi: 10.1111/cns.14063. Epub 2023 Jan 24.
6
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.NURR1 调控的神经炎症在帕金森病中的作用研究进展。
Int J Mol Sci. 2022 Dec 19;23(24):16184. doi: 10.3390/ijms232416184.
7
Stem Cell Transplantation for Parkinson's Disease: Current Challenges and Perspectives.帕金森病的干细胞移植:当前挑战与展望
Aging Dis. 2022 Dec 1;13(6):1652-1663. doi: 10.14336/AD.2022.0312.
8
Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson's disease in rats.小分子化合物在缺氧条件下诱导成纤维细胞来源的神经祖细胞用于治疗大鼠帕金森病
Neural Regen Res. 2023 May;18(5):1090-1098. doi: 10.4103/1673-5374.355820.
9
Roles of Transcription Factors in the Development and Reprogramming of the Dopaminergic Neurons.转录因子在多巴胺能神经元的发育和重编程中的作用。
Int J Mol Sci. 2022 Jan 13;23(2):845. doi: 10.3390/ijms23020845.
10
Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.帕金森病中由NR4A2(NURR1)转录因子减少所主导的临床试验中胶质细胞源性神经营养因子(GDNF)的失败。一项系统评价。
Front Aging Neurosci. 2021 Feb 24;13:645583. doi: 10.3389/fnagi.2021.645583. eCollection 2021.
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3999-4004. doi: 10.1073/pnas.1616874114. Epub 2017 Mar 27.
4
Parkinson's Disease: From Pathogenesis to Pharmacogenomics.帕金森病:从发病机制到药物基因组学
Int J Mol Sci. 2017 Mar 4;18(3):551. doi: 10.3390/ijms18030551.
5
Current and experimental treatments of Parkinson disease: A guide for neuroscientists.帕金森病的当前及实验性治疗方法:神经科学家指南
J Neurochem. 2016 Oct;139 Suppl 1:325-337. doi: 10.1111/jnc.13750. Epub 2016 Aug 30.
6
Nurr1-Based Therapies for Parkinson's Disease.基于Nurr1的帕金森病治疗方法。
CNS Neurosci Ther. 2016 May;22(5):351-9. doi: 10.1111/cns.12536. Epub 2016 Mar 25.
7
Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1.雌二醇通过激活整合素 α5β1 促进 iPSC 衍生的多巴胺能神经元整合到纹状体神经元回路中。
Stem Cell Reports. 2016 Apr 12;6(4):511-524. doi: 10.1016/j.stemcr.2016.02.008. Epub 2016 Mar 17.
8
Evidence for possible role of toll-like receptor 3 mediating virus-induced progression of pituitary adenomas.Toll样受体3介导病毒诱导垂体腺瘤进展的可能作用的证据。
Mol Cell Endocrinol. 2016 May 5;426:22-32. doi: 10.1016/j.mce.2016.02.009. Epub 2016 Feb 15.
9
Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.用于治疗帕金森病的选择性脑穿透性Nurr1反式激活因子
Oncotarget. 2016 Feb 16;7(7):7469-79. doi: 10.18632/oncotarget.7191.
10
Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.鉴定神经突触素3作为诱导多能干细胞来源的多巴胺能祖细胞存活的新型支持因子。
Stem Cells Transl Med. 2015 Aug;4(8):932-44. doi: 10.5966/sctm.2014-0197. Epub 2015 Jun 3.